Persistence to anti-cancer treatments in the stationary to proliferating transition

Keyphrases

• Cancer Cells 100%
• Anticancer Treatment 100%
• Mammalian Cells 50%
• Microenvironment 50%
• Treatment Regimen 50%
• Drug Response 50%
• Fluctuating Conditions 50%
• High Survival 50%
• Survival Rate 50%
• System Development 50%
• Drug Treatment 50%
• Quantitative Evaluation 50%
• Cell Cycle Phases 50%
• Phase-specific 50%
• Stochasticity 50%
• Persister Cells 50%
• Heterogeneous Response 50%
• Cell Cycle Dynamics 50%
• Cell Cycle Markers 50%
• Survival Probability 50%
• Tumor Cancer 50%
• Repeated Treatment 50%
• Lymphoblast 50%
• Transition Time 50%
• Mother Machine 50%
• Stationary Culture 50%
• L1210 Cells 50%

Biochemistry, Genetics and Molecular Biology

• Cell Cycle 100%
• Dynamics 66%
• Cancer Cell 66%
• Survival Rate 66%
• Quantitative Technique 33%
• Mammalian Cell 33%
• Cell Cycle Phase 33%
• Lymphoblast 33%
• L1210 Cells 33%